European in vitro diagnostic (IVD) cancer market to reach $400 million by the year 2002
This article was originally published in Clinica
The European in vitro cancer diagnostics market is predicted to rise to $399 million by 2002 from an estimated $325 million in 1995. Improved testing parameters and instrument consolidation are expected to stimulate growth, says a new report by Frost & Sullivan. DNA detection and in situ hybridisation techniques are cited as important developing areas.